Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/29/21 → 1/28/26 |
Funding
- Merck Sharp & Dohme Corporation: $41,654.77
A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants
- Rupp, Richard (PI)
Project: Other project